Depression: open trials in Hungary

5 open trials have a site in Hungary. Registry data; only the trial team decides who can take part.

NCT06966401
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Trial Treatment · Phase 3 · Neurocrine Biosciences
Nyírő Gyula Országos Pszichiátriai és Addiktológiai Intézet, Budapest · Semmelweis University, Budapest · Obudai Egeszseguegyi Centrum Kft., Budapest III · Gyoengyosi Bugat Pal Koerhaz, Gyongyos · Dr. Mathe Es Tarsa Bt., Kalocsa
Registry updated 2026-11-02
NCT07065240
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Trial Treatment · Phase 2 · Seaport Therapeutics
Processus Kft, Budapest · Semmelweis University, Budapest · Clinexpert Kft., Budapest III
Registry updated 2026-10-06
NCT07161700
An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)
Trial Treatment · Phase 2 · Seaport Therapeutics
Semmelweis University, Budapest · Processus Kft, Budapest · Clinexpert Kft., Budapest III · Psychotech Kft., Pécs
Registry updated 2026-10-06
NCT06963021
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Trial Treatment · Phase 3 · Neurocrine Biosciences
Nyírő Gyula Országos Pszichiátriai és Addiktológiai Intézet, Budapest · Semmelweis University, Budapest · Obudai Egeszseguegyi Centrum Kft., Budapest III · Gyoengyosi Bugat Pal Koerhaz, Gyongyos · Dr. Mathe Es Tarsa Bt., Kalocsa
Registry updated 2026-08-10
NCT07207239
Effect of Theta-burst rTMS Therapy on the Clinical and Cognitive Symptoms of Patients With Therapy Resistant Depression and Response Prediction With Neuroimaging Methods.
Trial Treatment · Semmelweis University
Department of Psychiatry and Psychotherapy, Budapest
Registry updated 2025-10-03

All Depression trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

Depression: open trials in Hungary

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Effect of Theta-burst rTMS Therapy on the Clinical and Cognitive Symptoms of Patients With Therapy Resistant Depression and Response Prediction With Neuroimaging Methods.